Evidence of a latent precursor (p53 signature) to uterine serous carcinoma

被引：0
|
作者：
Jarboe, E. A.
Pizer, E.
Miron, A.
Crum, C. P.
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Cell Netix Pathol, Seattle, WA USA
[3] Dana Farber Canc Inst, Boston, MA USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
950
引用
收藏
页码：208A / 208A
页数：1
相关论文
共 50 条
  • [41] A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
    Folkins, Ann K.
    Jarboe, Elke A.
    Saleemuddin, Aasia
    Lee, Yonghee
    Callahan, Michael J.
    Drapkin, Ronny
    Garber, Judy E.
    Muto, Michael G.
    Tworoger, Shelley
    Crum, Christopher P.
    GYNECOLOGIC ONCOLOGY, 2008, 109 (02) : 168 - 173
  • [42] High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
    Hatano, Yuichiro
    Fukuda, Shinya
    Makino, Hiroshi
    Tomita, Hiroyuki
    Morishige, Ken-ichirou
    Hara, Akira
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [43] High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
    Yuichiro Hatano
    Shinya Fukuda
    Hiroshi Makino
    Hiroyuki Tomita
    Ken-ichirou Morishige
    Akira Hara
    Diagnostic Pathology, 13
  • [44] Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: Evidence of a precursor lesion
    Lai, R
    ElDabbagh, L
    Mourad, WA
    MODERN PATHOLOGY, 1996, 9 (06) : 690 - 695
  • [45] P53 MUTATIONS OCCUR IN CLINICAL, BUT NOT LATENT, HUMAN PROSTATE CARCINOMA
    KONISHI, N
    HIASA, Y
    HAYASHI, I
    MATSUDA, H
    TSUZUKI, T
    MING, T
    KITAHORI, Y
    SHIRAISHI, T
    YATANI, R
    SHIMAZAKI, J
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 57 - 63
  • [46] The p53 Family Gene Signature Predicts Prognosis in Hepatocellular Carcinoma
    Staib, Frank
    Pelc, Agnes
    Eftekhar-Afzali, Shermineh
    Krupp, Markus
    Thorgeirsson, Snorri S.
    Galle, Peter R.
    Schilling, Tobias
    Wang, Xin W.
    Teufel, Andreas
    Mueller, Martina
    HEPATOLOGY, 2012, 56 : 618A - 619A
  • [47] The immune complex p53 protein/anti-p53 autoantibodies in the pathogenesis of ovarian serous carcinoma
    Mielczarek-Palacz, Aleksandra
    Sikora, Jstyna
    Kondera-Anasz, Zdislawa
    Smycz-Kubanska, Marta
    Englisz, Aleksandra
    Strzelczyk, Jaroslaw
    Kabut, Jacek
    GINEKOLOGIA POLSKA, 2020, 91 (09) : 519 - 523
  • [48] The innovative role of p53 unbalance in precancerous lesions for serous ovarian carcinoma
    Asaturova, A.
    Kogan, E.
    Ezhova, L.
    Zharkov, N.
    Fayzullina, N.
    VIRCHOWS ARCHIV, 2015, 467 : S133 - S133
  • [49] A case of serous endometrial intraepithelial carcinoma with p53 positivity for six years
    Kaku, Shoji
    Moriya, Takuya
    Ushioda, Norichika
    Nakai, Yuichiro
    Shimoya, Koichiro
    Nakamura, Takafumi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2012, 38 (02) : 455 - 460
  • [50] p53 and bcl-2 expression in invasive and pre-invasive uterine papillary serous carcinoma and atrophic endometrium
    Busmanis, I
    Ho, TH
    Tan, SB
    Khoo, KS
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2005, 34 (07) : 421 - 425
12345